Cadrenal Therapeutics, Inc. (CVKD) Misses Q2 EPS by 61c
Tweet
Share
E-mailGet Alerts CVKD Hot Sheet
Join SI Premium – FREE
Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) reported Q2 EPS of ($1.87), $0.61 worse than the analyst estimate of ($1.26). Revenue for the quarter came in at $0 , versus $0 reported last year.
For earnings history and earnings-related data on Cadrenal Therapeutics, Inc. (CVKD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Corning (GLW) files for up to $2B offering of common shares
- Citrini Research acquired by Semianalysis
- 37 Capital raises $300,000 in partial private placement closing
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
